MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on July 27, 2004; DOI: 10.1124/mol.104.002642


0026-895X/04/6605-1265-1274$20.00
Mol Pharmacol 66:1265-1274, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.002642v1
66/5/1265    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shen, J.
Right arrow Articles by Sturek, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shen, J.
Right arrow Articles by Sturek, M.

Cloning, Up-Regulation, and Mitogenic Role of Porcine P2Y2 Receptor in Coronary Artery Smooth Muscle Cells

Jianzhong Shen, Cheikh I. Seye, Meifang Wang, Gary A. Weisman, Peter A. Wilden, and Michael Sturek

Departments of Medical Pharmacology and Physiology (J.S., M.W., P.A.W., M.S.), Biochemistry (C.I.S., G.A.W.), and Internal Medicine (M.S.), and the Center for Diabetes and Cardiovascular Health (J.S., M.W., P.A.W., M.S.), University of Missouri-Columbia, School of Medicine, Columbia, Missouri

Previous work has shown up-regulation of a UTP-sensitive P2Y receptor in porcine coronary smooth muscle cells (CSMC) of organ-cultured arteries. However, the molecular identity and functional role of this putative receptor remained undefined. Here we report the cloning of the cDNA for this receptor that encodes an open reading frame for a protein of 373 amino acids with the highest homology to the human P2Y2 receptor (84%). Heterologous expression of this receptor in 1321N1 cells revealed a novel pharmacology in that UTP and ITP were full agonists and UTP was more potent and efficacious than ATP for increasing intracellular [Ca2+] and extracellular signal-regulated kinase phosphorylation. Stimulation of subcultured CSMC with UTP, ITP, or ATP induced a concentration-dependent increase in cellular DNA content, protein synthesis, cell number, and proliferating cell nuclear antigen expression, indicating a mitogenic role for P2Y2 receptors. This was supported by the finding that the treatment of CSMC with antisense oligonucleotides to the cloned cDNA sequence significantly inhibited UTP- and ATP-induced DNA and protein synthesis. In addition, reverse transcription-polymerase chain reaction analysis showed that P2Y2 receptor mRNA was dramatically increased in cells of organ-cultured arteries compared with freshly harvested arteries, whereas the P2Y6 receptor mRNA level was unchanged, and the P2Y4 receptor mRNA was undetectable. This P2Y2 subtype-specific up-regulation was confirmed in cells of coronary arteries stented in vivo. In conclusion, we have cloned the porcine P2Y2 receptor with novel pharmacology and demonstrated that this receptor is up-regulated in CSMC of in vitro organ cultures or in vivo stented coronary arteries to mediate the mitogenic effects of nucleotides.


Received for publication May 14, 2004.

Accepted for publication July 26, 2004.

Address correspondence to: Dr. Michael Sturek, Professor and Chair, Department of Cellular and Integrative Physiology, Indiana University, School of Medicine, 635 Barnhill Drive, MS 309, Indianapolis, IN 46202-5120. E-mail: msturek{at}iupui.edu




This article has been cited by other articles:


Home page
Circ. Res.Home page
J. Shen and P. E. DiCorleto
ADP Stimulates Human Endothelial Cell Migration via P2Y1 Nucleotide Receptor-Mediated Mitogen-Activated Protein Kinase Pathways
Circ. Res., February 29, 2008; 102(4): 448 - 456.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Jalvy, M.-A. Renault, L. Lam Shang Leen, I. Belloc, A. Reynaud, A.-P. Gadeau, and C. Desgranges
CREB Mediates UTP-Directed Arterial Smooth Muscle Cell Migration and Expression of the Chemotactic Protein Osteopontin via Its Interaction with Activator Protein-1 Sites
Circ. Res., May 11, 2007; 100(9): 1292 - 1299.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
M. P. Abbracchio, G. Burnstock, J.-M. Boeynaems, E. A. Barnard, J. L. Boyer, C. Kennedy, G. E. Knight, M. Fumagalli, C. Gachet, K. A. Jacobson, et al.
International Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to Therapy
Pharmacol. Rev., September 1, 2006; 58(3): 281 - 341.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Shen, S. P. Halenda, M. Sturek, and P. A. Wilden
Cell-Signaling Evidence for Adenosine Stimulation of Coronary Smooth Muscle Proliferation via the A1 Adenosine Receptor
Circ. Res., September 16, 2005; 97(6): 574 - 582.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Shen, S. P. Halenda, M. Sturek, and P. A. Wilden
Novel Mitogenic Effect of Adenosine on Coronary Artery Smooth Muscle Cells: Role for the A1 Adenosine Receptor
Circ. Res., May 13, 2005; 96(9): 982 - 990.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics